FindTrial
Sign In

Comparing two doses of Chloroprocaine for effective spinal Anaesthesia in patients receiving brachytherapy for carcinoma cervix

Comparision of Two doses of Chloroprocaine for effective Spinal Anaesthesia in Brachytherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019567
Enrollment
140
Registered
2019-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N879- Dysplasia of cervix uteri, unspecified Health Condition 2: C539- Malignant neoplasm of cervix uteri, unspecified Health Condition 3: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Chloroprocaine: Intrathecal Chloroprocaine in patients of carcinoma cervix posted for brachytherapy Control Intervention1: Chloroprocaine: Chloroprocaine 20mg and 30mg in spianl anaest

Sponsors

n sneha
Lead Sponsor
Namratha ranganath
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: patients belonging to ASA 1 and 2 patients consenting for study patients undergoing brachytherapy

Exclusion criteria

Exclusion criteria: patients belonging to ASA 3 and 4 patients who are contraindicated for spinal anaesthesia

Design outcomes

Primary

MeasureTime frame
onset of sensory blockade duration of motor blockade peak block heightTimepoint: every 3 minutes for first 15 min minutes,every 15 minutes for 1 hour, then every hour for next 24 hours—

Secondary

MeasureTime frame
Hemodynamics Timepoint: 24 hours—

Countries

India

Contacts

Public Contactn sneha

kidwai memorial institute of oncology

namrang@gmail.com9676964693

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026